Snowball logo
logo
RIGL_logo

Rigel Pharmaceuticals Inc

RIGL β€’ NASDAQ
$49.91+$1.78Β  (3.7%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
149.2120.2116.9179.3294.3276.8
COGS
1.0831.7497.1118.6519.6223.84
Gross Profit
148.2118.5109.8160.6274.7252.9
Operating Expenses & Income
Operating Income
(12.5)(55.55)(20.49)24.19125.587.05
Total Operating Expenses
160.6174130.3136.4149.2165.9
R&D Expenses
65.2460.2724.5223.3833.343.67
Selling General & Admin Expenses
91.89112.5111.1113.1115.9122.2
Earnings from Continuing Operations
Interest Expense
(4.86)(3.707)(6.872)(7.918)(7.32)(5.805)
Interest Income
0.0470.6842.0232.0923.6814.331
Income Tax Expense
0.6053.0232.2720.881(245.2)(236.3)
Net Income
Net Income
(17.91)(58.57)(25.09)17.48367321.9
Supplemental
EBIT
(12.45)(54.87)(18.22)26.28129.191.38
EBITDA
(11.29)(53.87)(16.98)28.51131.694.03
In millions of USD, except % and values per 1 share